The lowering of the price target by Oppenheimer could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside for the stock, which could counterbalance the negative sentiment to some extent.